| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |